Nalaganje...

Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase

Thirty patients with Parkinson's disease were treated for four weeks with levodopa combined with an inhibitor of extracerebral dopa decarboxylase, L-alpha-methyldopahydrazine (MK 486). The therapeutic results were compared with the effects of treatment of a group of 40 patients with levodopa al...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Marsden, C. D., Barry, P. E., Parkes, J. D., Zilkha, K. J.
Format: Artigo
Jezik:Inglês
Izdano: 1973
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC494269/
https://ncbi.nlm.nih.gov/pubmed/4691682
Oznake: Označite
Brez oznak, prvi označite!